Glyscend, Inc. reported raising $4.8 Million in an initial SEC Form D filing, from an offering of $20.9 Million
Amount Raised
$4.8 Million
Round Type
Seed
LowellBiotechnologyHealth CareTherapeuticsWho else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Glyscend, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Vaxcyte, Inc. raised $110M on April 3, 2020.
- Dyne Therapeutics raised an undisclosed amount on March 31, 2020.
- Windtree Therapeutics raised an undisclosed amount (Grant) on March 31, 2020.
- Medicenna raised $6.7M on March 30, 2020.
- CytoDyn raised $882K (Seed) on March 30, 2020.
- Olema Pharmaceuticals, Inc. raised $30M on March 27, 2020.
Who to call at Glyscend, Inc., and when
A new round usually means Glyscend, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Glyscend, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Glyscend, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Glyscend, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Glyscend, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Glyscend, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.